arrow back backwards u-turn turn around reverse
Pharma

Hims quits on obesity pill after legal, regulatory heat

Hims has quickly retreated from its launch of a compounded obesity pill after facing mounting pressure from the FDA and Novo Nordisk.
Fraiser Kansteiner Feb 9, 2026 10:24am
Food and Drug Administration

Regulatory tracker: Scotland issues 2nd thumbs down to Kisunla

Feb 9, 2026 1:00pm
Community oncologys growing role in the future of cancer care

Community oncology’s growing role in the future of cancer care

Feb 9, 2026 8:00am
Otsuka

Otsuka awareness campaign urges HCPs to see ‘All of ADHD’

Feb 9, 2026 12:22pm
Photo of two hands shaking

Fresenius, Phlow link up to boost US epinephrine injection supply

Feb 9, 2026 11:08am
Illustration of two hands against a blue background one holding a bright yellow and pink alarm clock the other holding a ye

Editor’s Corner: Pharma's slack tightening across pipelines, trust

Feb 9, 2026 3:00am
More News

Lilly lauds scientific, athletic progress in Winter Olympics ad

Feb 6, 2026 5:00pm
Fierce Biotech

Genentech cut at least 489 jobs last year, new filing reveals

Feb 6, 2026 1:38pm

Biogen bets HD Spinraza can outmuscle Roche's oral rival

Feb 6, 2026 12:02pm
Fierce Healthcare

HHS agrees to toss 340B Rebate Model Pilot Program

Feb 6, 2026 11:00am